Selvita acquires in Croatia
Selvita, which specialises in laboratory research and development services for external customers, has announced the conclusion of its first acquisition…
Selvita, which specialises in laboratory research and development services for external customers, has announced the conclusion of its first acquisition…
Ryvu Therapeutics (formerly Selvita), a Polish biotechnology company, is expanding its plans for R&D projects. By the end of 2022,…
The company’s new strategy for 2020-2023 assumes a three-fold increase in revenues. This will be achieved through acquisitions and organic…
Selvita, which specialises in laboratory research and development services for external customers, wants to increase the scale of its operations…
The last few days have brought a lot of changes in the biotechnological company Selvita. The company’s shareholders agreed to…
Dr. Setareh Shamsili became the new Chief Medical Officer at Selvita. This is another personnel change in the Polish biotechnology…
Further personnel changes in the Polish biotechnology company Selvita. Dr. Tom Coulter has been appointed to the position of the…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.